Health Condition 1: C61- Malignant neoplasm of prostate
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Confirmed prostatic carcinoma 2. Will undergo radiation therapy - radical radiation therapy or prostate-directed radiation therapy 3. Is on androgen deprivation therapy with either medical or surgical methods and is planned to be on this for a minimum duration of 6 months 4. ECOG Performance status 0-1 5. Signed study-specific consent form 6. Patient willing and reliable for follow-up
Exclusion criteria
Exclusion criteria: Patients should have none of the following 1. ECOG Performance status 2 or more 2. Limitation in mobility and/or comorbidities that will prevent them from complying to exercise requirements 3. Unable to follow up or poor logistic or social support 4. Deemed to be at high risk of harm due to the presence of lytic bone metastases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in the Quality of Life as measured by FACIT-FTimepoint: At 24 weeks and at 36 weeks after the start of ADT | — |
Secondary
| Measure | Time frame |
|---|---|
| Adherence to the prescribed exercise protocol measured at 24 weeks and at 36 weeks after the start of ADTTimepoint: At 24 weeks and at 36 weeks after the start of ADT;Body Composition of the patientsTimepoint: At 24 weeks and at 36 weeks after the start of ADT;Changes in the Quality of Life as measured by FACT-G and EORTC - PR25Timepoint: At 24 weeks and at 36 weeks after the start of ADT;Functional performance of the patientsTimepoint: At 24 weeks and at 36 weeks after the start of ADT | — |
Countries
India
Contacts
Tata Medical Center, Kolkata